Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 4 of ec50 for monomerid = 107701
TargetVascular endothelial growth factor A(Human)
Akebia Therapeutics

US Patent
LigandPNGBDBM107701(US11426393, Compound Table XV.7 | US8598210, Table...)
Affinity DataEC50:  7.70E+3nMAssay Description:HEK293 cells are seeded in 96-well poly-lysine coated plates at 20,000 cells per well in DMEM (10% FBS, 1% NEAA, 0.1% glutamine). Following overnight...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetVascular endothelial growth factor receptor 1(Human)
Akebia Therapeutics

US Patent
LigandPNGBDBM107701(US11426393, Compound Table XV.7 | US8598210, Table...)
Affinity DataEC50:  7.70E+3nMAssay Description:HEK293 cells are seeded in 96-well poly-lysine coated plates at 20,000 ceils per well in DMEM (10% FBS, 1% NEAA, 0.1% glutamine). Following overnight...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetVascular endothelial growth factor A(Human)
Akebia Therapeutics

US Patent
LigandPNGBDBM107701(US11426393, Compound Table XV.7 | US8598210, Table...)
Affinity DataEC50:  7.70E+3nMAssay Description:HEK293 cells are seeded in 96-well poly-lysine coated plates at 20,000 cells per well in DMEM (10% FBS, 1% NEAA, 0.1% glutamine). Following overnight...More data for this Ligand-Target Pair
In DepthDetails US Patent

TargetVascular endothelial growth factor A(Human)
Akebia Therapeutics

US Patent
LigandPNGBDBM107701(US11426393, Compound Table XV.7 | US8598210, Table...)
Affinity DataEC50:  7.70E+3nMMore data for this Ligand-Target Pair
In DepthDetails US Patent